Background: Venous thromboembolism (VTE) is a common complication among patients
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …

Patients with active cancer are at an increased risk of arterial and venous thromboembolism
(VTE) and bleeding events. Historically, in patients with cancer, low molecular weight …

2.1. 1. Epidemiology and burden of the disease. The annual incidence of first episode of
symptomatic DVT in the adult population ranges from 50 to 100 per 100 000 population, with …

Thromboembolism in people with cancer still remains a major health problem and is a
leading cause of mortality after cancer itself, despite being a largely preventable disease. 1 …

A panel of experts was convened by the Infectious Diseases Society of America (IDSA) to
update the 2004 clinical practice guideline on outpatient parenteral antimicrobial therapy …

Patients with cancer-associated thrombosis (CAT) are at high risk of recurrent venous
thromboembolism (VTE) and major bleeding complications. Risks vary significantly between …

Upper extremity deep vein thrombosis (UEDVT) accounts for 5% of all deep vein
thromboses (DVTs). UEDVT may be complicated by post thrombotic syndrome and …

Management of anticoagulant therapy for the treatment of venous thromboembolism (vte) in
cancer patients is complex because of an increased risk of recurrent vte and major bleeding …

Abstract In 2011, the Spanish Society of Medical Oncology (SEOM) first published a clinical
guideline of venous thromboembolism (VTE) and cancer. This guideline was updated in …

Background In recent years, knowledge about cancer associated thrombosis has evolved
considerably. Methods Practical guidelines were drafted on the initiative of the INNOVTE …